Open AccessCombined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
Author(s) -
Pukhraj Rishi,
Ekta Rishi,
Daraius Shroff
Publication year - 2009
Publication title -
indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.49406
Subject(s) - medicine , bevacizumab , ophthalmology , macular telangiectasia , visual acuity , fundus (uterus) , photodynamic therapy , fluorescein angiography , choroidal neovascularization , ranibizumab , surgery , chemotherapy , chemistry , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom